Pharma Journalist -

SMi Group reports: Exclusive interview with Grace Macaulay - MedImmune released in the run up to the Immuno-Oncology Conference, taking place on the 26 - 27 September 2018 in London.…
Read More...

SMi Group reports: William J. Weiss - University of North Texas Health Science Center and Anthony Simon Lynch - Janssen supporting SMi's Superbugs & Superdrugs USA Conference, which…
Read More...

SMi Reports: An exclusive interview with Dr Michel Mikhail, an independent consultant and chairman of this year’s Biosimilars & Biobetters conference, is now available to download…
Read More...

Merck announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review for a new supplemental Biologics License Application (sBLA) seeking approval…
Read More...

Sirona Biochem Corp. announced that partner, Jiangsu Wanbang Biopharmaceuticals, has confirmed the Investigational New Drug (IND) submission to China’s Food and Drug Administration…
Read More...

Antabio SAS, a biopharmaceutical company developing novel antibacterial treatments in areas of highest unmet needs, announced today it has extended its Series A financing round with an…
Read More...

Immatics Biotechnologies announced that it has entered into a research collaboration and license agreement with Genmab A/S to develop next-generation, T-cell engaging bispecific…
Read More...

Genmab A/S announced that it has entered into a research collaboration and exclusive license agreement with privately owned Immatics Biotechnologies GmbH (Immatics), to discover and…
Read More...

Pfenex Inc. announced the receipt of a milestone payment from Merck associated with the initiation of the first Phase 3 clinical study of (V114), an investigational polyvalent conjugate…
Read More...

UL announced that together with Applied DNA Sciences Inc. they have joined forces to form a strategic partnership that will lay the foundation for a significant new development in…
Read More...